Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.485 USD | +1.43% | -4.25% | +45.88% |
Apr. 23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
Mar. 21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.88% | 368M | |
+2.70% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-12.36% | 26.59B | |
+8.02% | 25.49B | |
-22.97% | 18.12B | |
+31.32% | 12.24B | |
-1.40% | 11.76B | |
+8.51% | 11B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Earnings Flash (HRTX) HERON THERAPEUTICS Posts Q4 Revenue $34.2M, vs. Street Est of $31.2M